Voyager Reports Second Quarter 2025 Financial and Operating Results

- Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs -

- APOE program added to pipeline; fourth asset in industry-leading Alzheimer’s disease franchise -

Read more at globenewswire.com